← Evidence map

ArticleEndocrine2022

Sorafenib decreases glycemia by impairing hepatic glucose metabolism.

Jingjing Ma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36205915